Fortive Corp
For the period ended Jul 30, 2025. Filed Jul 30, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jul 30, 2025 · Filed Jul 30, 2025
Contents
EX-99.1 · Continuing Operations: Segment Adjusted EBITDA, Segment Adjusted EBITDA Margin (unaudited)
Continuing Operations: Segment Adjusted EBITDA, Segment Adjusted EBITDA Margin (unaudited)
| Three Months Ended June 27, 2025 | Three Months Ended June 28, 2024 | |||
|---|---|---|---|---|
| $ in millions | Intelligent Operating Solutions | Advanced Healthcare Solutions | Intelligent Operating Solutions | Advanced Healthcare Solutions |
| Revenue (GAAP) | $696.9 | $319.5 | $696.6 | $323.6 |
| Operating Profit (GAAP) | $170.8 | $35.8 | $173.4 | $35.7 |
| Amortization of acquisition-related intangible assets | 46.6 | 45.0 | 47.2 | 45.3 |
| Acquisition and divestiture related items | 0.4 | — | 1.4 | — |
| Discrete restructuring charges | 5.9 | — | — | — |
| Adjusted Operating Profit (Non-GAAP) | 223.7 | 80.8 | 222.0 | 81.0 |
| Depreciation | 12.0 | 5.3 | 10.0 | 5.1 |
| Adjusted EBITDA (Non-GAAP) | $235.7 | $86.1 | $232.0 | $86.1 |
| Operating Profit Margin (GAAP) | 24.5% | 11.2% | 24.9% | 11.0% |
| Adjusted Operating Profit Margin (Non-GAAP) | 32.1% | 25.3% | 31.9% | 25.0% |
| Adjusted EBITDA Margin (Non-GAAP) | 33.8% | 26.9% | 33.3% | 26.6% |
Adjusted Net Earnings from Continuing Operations and Adjusted Diluted Net Earnings Per Share from Continuing Operations Reflecting Ralliant as Discontinued Operations (unaudited)
| Three Months Ended | ||||||
|---|---|---|---|---|---|---|
| ($ in millions, except per share amounts) · June 27, 2025 · June 28, 2024 | ||||||
| Per share values · Per share values | ||||||
| Net Earnings and Net Earnings Per Share from Continuing Operations (GAAP) | $111.6 | $0.33 | $112.0 | $0.32 | ||
| Pretax amortization of acquisition related intangible assets | 91.6 | 0.27 | 92.5 | 0.26 | ||
| Pretax acquisition, divestiture, and separation related items | 1.6 | — | 1.4 | — | ||
| Pretax discrete restructuring charges | 8.0 | 0.02 | — | — | ||
| Pretax losses from equity investments | — | — | 8.5 | 0.02 | ||
| Pretax gain from divestiture | (2.1) | (0.01) | — | — | ||
| Tax effect of the adjustments reflected above | (12.9) | (0.03) | (15.8) | (0.04) | ||
| Adjusted Net Earnings and Adjusted Net Earnings Per Share from Continuing Operations (Non-GAAP) | $197.8 | $0.58 | $198.6 | $0.56 | ||
| Average Common Diluted Stock Outstanding (shares in millions) | 341.7 | 354.8 | ||||
| The sum of the components of adjusted diluted net earnings per share may not equal due to rounding. | ||||||
Free Cash Flow from Continuing Operations Reflecting Ralliant as Discontinued Operations - Trailing Twelve Months (unaudited)
| ($ in millions) · Three Months Ended · Trailing Twelve Months | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| June 27, 2025 · March 28, 2025 · December 31, 2024 · September 27, 2024 | |||||||||
| Operating Cash Flows (GAAP) | $205.0 | $191.8 | $327.7 | $304.7 | $1,029.2 | ||||
| Less: Purchases of property, plant & equipment (capital expenditures) (GAAP) | (25.0) | (21.1) | (22.6) | (21.6) | (90.3) | ||||
| Free Cash Flow (Non-GAAP) | $180.0 | $170.7 | $305.1 | $283.1 | $938.9 | ||||
| ($ in millions) · Three Months Ended · Trailing Twelve Months | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| June 28, 2024 · March 29, 2024 · December 31, 2023 · September 29, 2023 | |||||||||
| Operating Cash Flows (GAAP) | $217.5 | $178.6 | $259.8 | $256.4 | $912.3 | ||||
| Less: Purchases of property, plant & equipment (capital expenditures) (GAAP) | (19.6) | (22.3) | (23.4) | (20.6) | (85.9) | ||||
| Free Cash Flow (Non-GAAP) | $197.9 | $156.3 | $236.4 | $235.8 | $826.4 | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.